GSK travel vaccines
Ended Awarded Last action
- Contract number
- 15F06725F0000309
- Awardee
-
Glaxosmithkline, LLC UEI FRHTPHMZMX47
- Awarding agency
-
Headquarters Division
Federal Bureau of Investigation, Department of Justice
- Obligated
- $117,000
Award facts
- Contract value 100% obligated
- $117,000.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Durham, NC 27701, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | $57,000 | |
| Original award | $60,000 |
About this award
This federal contract award to Glaxosmithkline, LLC, a foreign-owned, for-profit pharmaceutical company, is for the supply of GSK Travel Vaccines. The contract is a Blanket Purchase Agreement (BPA) Call with a Firm Fixed Price (FFP) pricing type, valued at $117,000.00, and has an ultimate completion date of December 31, 2025. The award was made on February 27, 2025 by the Department of Justice, Headquarters Division, a civilian federal agency.
Glaxosmithkline, LLC has been awarded multiple significant federal Indefinite Delivery Contracts (IDVs), particularly with the Centers for Disease Control and Prevention (CDC) and the Department of Veterans Affairs, covering a wide range of vaccine procurement, including pediatric and adult vaccination programs. The company also holds a Federal Supply Schedule contract with a maximum ceiling of $3.9 billion, covering pharmaceutical products and medical supplies. These IDVs and contract vehicles support critical national immunization efforts, allowing federal agencies to place task orders for vaccines with specific quantities and delivery requirements.
Quick answers
Who was awarded contract 15F06725F0000309?
15F06725F0000309 was awarded to Glaxosmithkline, LLC by Headquarters Division (Federal Bureau of Investigation) on February 27, 2025.
How much is contract 15F06725F0000309 worth?
The government has obligated $117,000 on 15F06725F0000309.
Is contract 15F06725F0000309 an order under another contract?
Yes. 15F06725F0000309 is a BPA call under 15F06722A0000187, a blanket purchase agreement.
Was contract 15F06725F0000309 competed?
The extent of competition for 15F06725F0000309 was competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award